加载中
NYSEHealthcareMedical - Healthcare Information Services
最新数据
US$4.04
+US$0.08 · +2.02%
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
前收盘价
US$4.04
+US$0.08 · +2.02%
盘中时间采用ET。市场数据可能有所延迟。
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
日内区间
当前US$4.04
52周区间
当前US$4.04
盘中时间采用ET。市场数据可能有所延迟。
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
日内区间
当前US$4.04
52周区间
当前US$4.04
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 18.76亿 USD | 25.55亿 USD | 19.64亿 USD | 13.52亿 USD | 9.08亿 USD |
| 销货成本 | 15.92亿 USD | 21.87亿 USD | 15.03亿 USD | 10.35亿 USD | 6.58亿 USD |
| 毛利 | 2.84亿 USD | 3.67亿 USD | 4.6亿 USD | 3.17亿 USD | 2.5亿 USD |
| 研究与开发 | — | — | — | 2700万 USD | — |
| 销售、一般及管理费用 | 2.88亿 USD | 2.63亿 USD | 3.58亿 USD | 2.69亿 USD | 2.19亿 USD |
| 营业费用 | 2.88亿 USD | 4.08亿 USD | 5.32亿 USD | 3.13亿 USD | 2.93亿 USD |
| 利息收入 | 419万 USD | 554.4万 USD | 525.6万 USD | 136.9万 USD | 40.7万 USD |
| 利息支出 | 5747.1万 USD | 2472.2万 USD | 5420.5万 USD | 1557.2万 USD | 2542.5万 USD |
| 折旧和摊销 | 1.16亿 USD | 1.18亿 USD | 1.23亿 USD | 9025.1万 USD | 6003.7万 USD |
| 营业利润 | −443.5万 USD | −4048.5万 USD | −7121.1万 USD | 364.2万 USD | −4241.1万 USD |
| 净利润 | −5.35亿 USD | −6162.3万 USD | −1.13亿 USD | −1916.4万 USD | −3760.1万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$7.00
上涨空间 73.27%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1523.18万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM1172.59万0.01%787.4亿 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF592.5万0.01%954亿 USD0.05%US$235+0.80%
Schwab Fundamental U.S. Small Company Index ETFFNDA452.69万0.05%87.82亿 USD0.25%US$35.62+0.17%
Janus Henderson Small/Mid Cap Growth Alpha ETFJSMD331.74万0.32%10.5亿 USD0.30%US$91.44+1.13%
Vanguard Russell 2000 ETFVTWO295.83万0.02%180亿 USD0.06%US$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA217.41万0.01%218.24亿 USD0.03%US$32.79+0.40%
Vanguard U.S. Value Factor ETFVFVA155.84万0.18%9.57亿 USD0.13%US$153.78-0.36%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFSchwab Fundamental U.S. Small Company Index ETFFNDAJanus Henderson Small/Mid Cap Growth Alpha ETFJSMDVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAVanguard U.S. Value Factor ETFVFVAAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。